[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334884-105":59,"doc-detail-334884-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","patients-with-gynecological-malignancies-are-similar-to-other-ivf-patients-without-cancer-for-clinical-and-molecular-reproductive-parameters-and-dna-damage-response-pattern","Patients with gynecological malignancies are similar to other IVF patients without cancer for clinical and molecular reproductive parameters and DNA damage response pattern","","Investigate whether gynecological cancers impair ovarian function and reduce assisted reproduction technique (ART) success, combining clinical outcomes with molecular profiling. Granulosa cells from 39 women with gynecological malignancies undergoing oocyte or embryo freezing were analyzed alongside ART characteristics and compared with 31 cancer-free IVF control patients. The study found similar mature oocyte yield, fertilization rates, and embryo development competence. Molecular assays showed no disruptions in gonadotropin receptor expression/response, sex steroid production, cholesterol utilization or storage, or DNA damage response patterns, supporting reassuring clinical and molecular evidence that such malignancy does not harm ovarian functioning at the molecular level.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/patients-with-gynecological-malignancies-are-similar-to-other-ivf-patients-without-cancer-for-clinical-and-molecular-reproductive-parameters-and-dna-damage-response-pattern/334884/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/patients-with-gynecological-malignancies-are-similar-to-other-ivf-patients-without-cancer-for-clinical-and-molecular-reproductive-parameters-and-dna-damage-response-pattern/334884.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Does the study show that gynecological malignancies reduce IVF outcomes compared with cancer-free patients?","Question",{"text":113,"@type":114},"No. Women with gynecological malignancies had similar mature oocyte retrieval numbers, fertilization rates, and embryo development competency compared with control IVF patients without cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What molecular features of granulosa cells were evaluated in the cancer and control groups?",{"text":118,"@type":114},"The study assessed gonadotropin receptor expression and response, sex steroid production, cholesterol utilization/storage, and DNA damage response patterns in granulosa cells collected during oocyte retrieval.",{"name":120,"@type":111,"acceptedAnswer":121},"Do gynecological cancers alter DNA damage response patterns in granulosa cells during ART?",{"text":122,"@type":114},"The molecular analyses did not detect perturbations in the DNA damage response pattern when compared with control IVF patients without cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334884,1790216858,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPatients with gynecological malignancies are similar to other IVF patients without cancer for clinical and molecular reproductive parameters and DNA damage response pattern  \nYashar Esmaeilian1, Sevgi Yusufoglu2, Ece İltumur2, Deniz Ugurlu Cimen1,  \nDogan Vatansever3, Cagatay Taskiran3, Volkan Turan4, Kayhan Yakin1,2,3, Said İncir 5, Bulent Urman3 & Ozgur Oktem1,2,3*  \nThis study intended to investigate if gynecological cancers compromise ovarian function and reduce the success of assisted reproduction techniques (ART) . No clinical and molecular data together is available on this issue for gynecological or other organ cancers. Steroidogenic pathways and DNA damage response characteristics of the granulosa cells retrieved from the 39 gynecological cancer patients were analyzed together with their clinical ART characteristics in comparison to 31 control ART patients. Patients with gynecological malignancies were similar to the control IVF patients for the number of mature oocytes retrieved, fertilization rates and embryo development competency. Molecular analyses of the granulosa cells retrieved from these cancer patients did not detect any perturbations in gonadotropin receptor expression and response, sex steroid production, cholesterol utilization/storage and, DNA damage response pattern in comparison to control IVF patients without cancer. This study provides the first reassuring clinical and molecular combined data set that the presence of gynecological malignancy does not appear to have any detrimental effect on clinical IVF cycle characteristics and ovarian functioning at molecular level.  \nModern combined cytotoxic chemotherapy and radiation regimens for cancer treatment have toxic effects on ovarian follicles, affecting both dormant primordials and growing follicle fractions. The cardinal pathophysiologic event of ovarian damage after cancer treatment is the apoptotic death ofoocytes, granulosa cells and surrounding stroma, leading to follicle atresia and early exhaustion of the follicle stockpile1–5. Assisted reproduction technologies [Controlled ovarian stimulation (COS) with gonadotropin hormones for oocyte/embryo freezing] before exposure to gonadotoxic treatment modalities and/or cancer surgery is currently the most established method with the highest success rate in preserving fertility of adult women with cancer according to the mostrecent fertility preservation guidelines3. Besides the detrimental effects of chemotherapy and radiation, cancer itself may adversely affect ovarian reserve and functioning. Several studies and meta-analyses demonstrated that patients diagnosed with cancer, particularly those with hematological malignancies and those who carry germline BRCA mutations are more likely to have diminished ovarian reserve and shortened reproductive lifespan6,7. Nevertheless, available evidence regarding the impact of cancer diagnosis itself on reproductive performance is rather inconsistent largely because of heterogeneity in patient population and types of cancer8–12. A recent meta-analysis of 41 studies demonstrated that women with cancer may be less likely to achieve pregnancy and live birth after embryo transfer. However, there was a substantial among-study heterogeneity in the clinical  \n1Research Center for Translational Medicine, Koç University, Istanbul 34450, Turkey. 2The Graduate School of Health Sciences, Koç University, Istanbul 34450, Turkey. 3Department of Obstetrics and Gynecology, School of Medicine, Koc University, Davutpasa, Topkapi, 34010 Istanbul, Turkey. 4Department of Obstetrics and Gynecology,İstanbul Health and Technology University Faculty of Medicine, Istanbul, Turkey. 5Department of Biochemistry, Koç University School of Medicine, Istanbul, Turkey.* email: [ooktem@ku.edu.tr](ooktem@ku.edu.tr)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nindicators ofthe response of the","cbCaivUIdbXfSTdY","https://ap.wps.com/l/cbCaivUIdbXfSTdY","pdf",4854366,"English","# Patients and methods\n## Patients\n## Ovarian stimulation and ART context","[{\"question\":\"Does the study show that gynecological malignancies reduce IVF outcomes compared with cancer-free patients?\",\"answer\":\"No. Women with gynecological malignancies had similar mature oocyte retrieval numbers, fertilization rates, and embryo development competency compared with control IVF patients without cancer.\"},{\"question\":\"What molecular features of granulosa cells were evaluated in the cancer and control groups?\",\"answer\":\"The study assessed gonadotropin receptor expression and response, sex steroid production, cholesterol utilization/storage, and DNA damage response patterns in granulosa cells collected during oocyte retrieval.\"},{\"question\":\"Do gynecological cancers alter DNA damage response patterns in granulosa cells during ART?\",\"answer\":\"The molecular analyses did not detect perturbations in the DNA damage response pattern when compared with control IVF patients without cancer.\"}]","Patients with gynecological malignancies are similar to other IVF patients without cancer for clinical and molecular reproductive parameters and DNA damage response pattern | PDF",1790008740,25]